GE HEALTHCARE TECHNOLOGY (GEHC) Stock Analyst Earnings Estimates
NASDAQ:GEHC - Nasdaq - US36266G1076 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.341B 4.30% | 19.552B 6.60% | 19.672B 0.61% | 20.39B 3.65% | 21.334B 4.63% | 22.311B 4.58% | 23.907B 7.15% | |
| EBITDA YoY % growth | 3.155B -7.75% | 3.045B -3.49% | 3.205B 5.25% | 4.009B 25.09% | 4.232B 5.56% | 4.422B 4.49% | 4.691B 6.08% | |
| EBIT YoY % growth | 2.522B -9.77% | 2.435B -3.45% | 2.625B 7.80% | 3.347B 27.50% | 3.689B 10.22% | 4.051B 9.81% | 4.458B 10.05% | |
| Operating Margin | 13.75% | 12.45% | 13.34% | 16.41% | 17.29% | 18.16% | 18.65% | |
| EPS YoY % growth | N/A | 3.94 10.02% | 4.49 13.96% | 4.78 6.49% | 5.30 10.94% | 5.92 11.51% | 6.28 6.22% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.93 3.51% | 1.11 11.15% | 1.23 8.26% | 1.51 4.08% | 1.06 14.15% | 1.25 12.19% | 1.33 7.45% | 1.61 6.62% |
| Revenue Q2Q % growth | 4.755B 2.26% | 4.986B 3.04% | 5.055B 3.95% | 5.582B 4.94% | 4.937B 3.83% | 5.183B 3.95% | 5.251B 3.88% | 5.824B 4.34% |
| EBITDA Q2Q % growth | 810.31M 17.78% | 911.42M 0.71% | 987.54M -11.51% | 1.165B -15.64% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 683.07M 26.49% | 781.08M 28.47% | 858.98M 27.07% | 1.025B 27.97% | 684.93M 0.27% | 788.46M 0.94% | 857.31M -0.19% | 1.053B 2.73% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 1.45 22.88% | 1.29 | 0.16 | 12.49% |
| Q3 2024 Q2Q % growth | 1.14 15.15% | 1.07 | 0.07 | 6.17% |
| Q2 2024 Q2Q % growth | 1.00 8.70% | 1.00 | 0.00 | 0.18% |
| Q1 2024 Q2Q % growth | 0.90 5.88% | 0.92 | -0.02 | -2.68% |
| Q4 2023 Q2Q % growth | 1.18 -9.92% | 1.09 | 0.09 | 8.08% |
| Q3 2023 Q2Q % growth | 0.99 | 0.91 | 0.08 | 8.23% |
| Q2 2023 Q2Q % growth | 0.92 | 0.89 | 0.03 | 3.67% |
| Q1 2023 Q2Q % growth | 0.85 | 0.81 | 0.04 | 5.15% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 5.319B 2.17% | 5.437B | -118M | -2.17% |
| Q3 2024 Q2Q % growth | 4.863B 0.85% | 4.966B | -103M | -2.07% |
| Q2 2024 Q2Q % growth | 4.839B 0.46% | 4.97B | -131M | -2.64% |
| Q1 2024 Q2Q % growth | 4.65B -1.21% | 4.897B | -247M | -5.04% |
| Q4 2023 Q2Q % growth | 5.206B 5.43% | 5.193B | 13M | 0.25% |
| Q3 2023 Q2Q % growth | 4.822B 5.38% | 4.901B | -79M | -1.61% |
| Q2 2023 Q2Q % growth | 4.817B -45.43% | 4.89B | -73M | -1.49% |
| Q1 2023 Q2Q % growth | 4.707B | 4.727B | -20M | -0.42% |
| Q4 2022 Q2Q % growth | 4.938B 7.61% | % | ||
| Q3 2022 Q2Q % growth | 4.576B 6.32% | % | ||
| Q2 2022 Q2Q % growth | 8.827B 1.55% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -7.49% | -8.03% | 0.53% | 0.39% |
| Revenue | -1.94% | -2.44% | -1.87% | -2.45% |